Parkinson's disease (PD) is the second most common neurodegenerative disease in the U.S. The coremotor symptoms of PD are attributable to the degeneration of the mesencephalic dopaminergic neurons andalterations in the activity of neurons in the basal ganglia. In PD patients and in primate PD models, neuronsin two key nuclei of the basal ganglia - the external segment of the globus (GPe) and the subthalamic nucleus(STN) - spike in synchronous, high frequency rhythmic bursts.This pathophysiological activity is thought to beresponsible for bradykinesia, akinesia and rigidity in PD patients.Theoretical studies suggest that autonomouspacemaking in GPe neurons counter-balances the natural tendency of the reciprocally connected, STN-GPenetwork to transition into the pathological synchronous, rhythmic bursting seen in PD. The model that hasdominated the field for the last two decades has assumed that following DA depletion there is an elevation instriatopallidal GABAergic inhibitory input to the GPe, leading to a suppression of this autonomous activity.In the course of pursuing this hypothesis, we discovered that DA depletion induces a change in the intrinsicproperties of GPe neurons that results in the loss of autonomous pacemaking. Moverover, this loss appearsto be attributable to the down-regulation of a single ion channel subunit (HCN2). It is our central hypothesisthat the loss of autonomous pacemaking is responsible for the emergence of synchronous rhythmic burstingof the STN-GPe network in PD and that reversing this adaptation will not only diminish the pathophysiologyin this network, it will alleviate the motor symptoms ofPD. This project blends the skills of the labs of Drs.Surmeier, Wilson, Kita and Osten to pursue four specific aims addressing the basic mechanisms underlyingthis 'silencing' in rodent and monkey models of PD as well as strategies that could be used in PD patients tocorrect the deficit.
Our aims are:1) to characterize the mechanisms governing the rate and regularity of autonomous pacemaking in GPeneurons and their adaptation in rodent PD models (Wilson);2) to characterize the mechanisms governing the suppression of pacemaking in GPe neurons in rodent PDmodels and to develop a means for its restoration (Surmeier, Osten, Kita);3) to characterize subthalamo-pallidal glutamatergic signaling in rodent PD models and its potential role insuppression of pacemaking (Surmeier);4) to characterize the role of subthalamo-pallidal synaptic signaling in controlling GPe activity and itsadaptations in a monkey model of PD (Kita).Lay summary: These studies are aimed at correcting dysfunctional brain activity in late stage PD. Thesuccessful attainment of our aims could not only provide a novel, gene therapy for late stage PD but open newavenues for pharmacological treatment.
| Hunt Jr, Albert J; Dasgupta, Rajan; Rajamanickam, Shivakumar et al. (2018) Paraventricular hypothalamic and amygdalar CRF neurons synapse in the external globus pallidus. Brain Struct Funct 223:2685-2698 |
| Guzman, Jaime N; Ilijic, Ema; Yang, Ben et al. (2018) Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress. J Clin Invest 128:2266-2280 |
| Higgs, Matthew H; Wilson, Charles J (2017) Measurement of phase resetting curves using optogenetic barrage stimuli. J Neurosci Methods 289:23-30 |
| Surmeier, D James; Obeso, José A; Halliday, Glenda M (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18:101-113 |
| Chu, Hong-Yuan; McIver, Eileen L; Kovaleski, Ryan F et al. (2017) Loss of Hyperdirect Pathway Cortico-Subthalamic Inputs Following Degeneration of Midbrain Dopamine Neurons. Neuron 95:1306-1318.e5 |
| Shi, Han; Deng, Han-Xiang; Gius, David et al. (2017) Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress. Hum Mol Genet 26:1915-1926 |
| Surmeier, D James; Halliday, Glenda M; Simuni, Tanya (2017) Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease. Exp Neurol 298:202-209 |
| Galtieri, Daniel J; Estep, Chad M; Wokosin, David L et al. (2017) Pedunculopontine glutamatergic neurons control spike patterning in substantia nigra dopaminergic neurons. Elife 6: |
| Surmeier, D James; Schumacker, Paul T; Guzman, Jaime D et al. (2017) Calcium and Parkinson's disease. Biochem Biophys Res Commun 483:1013-1019 |
| Burbulla, Lena F; Song, Pingping; Mazzulli, Joseph R et al. (2017) Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease. Science 357:1255-1261 |
Showing the most recent 10 out of 119 publications
